title: [Requirements in clinical evaluation of drugs in oncology. Guidelines of the phase I/II study group of the Professional Society of Internal Oncology of the German Cancer Society].
authors.forename: W
authors.initials: W
authors.lastname: Queisser
authors.forename: R
authors.initials: R
authors.lastname: Hermann
authors.forename: L
authors.initials: L
authors.lastname: Edler
authors.forename: D
authors.initials: D
authors.lastname: Boerner
authors.forename: A
authors.initials: A
authors.lastname: Hinke
authors.forename: A
authors.initials: A
authors.lastname: Kaplan
authors.forename: R
authors.initials: R
authors.lastname: Pechan
authors.forename: M
authors.initials: M
authors.lastname: Peukert
authors.forename: H
authors.initials: H
authors.lastname: Rieder
authors.forename: R
authors.initials: R
authors.lastname: Sterz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation / Q000379:methods*; D005858:Germany; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Anforderungen an die klinische Pruefung von Arzneimitteln in der Onkologie. Richtlinien der Phase-I/II-Studiengruppe der Arbeitsgemeinschaft für Internistische Onkologie (AIO) der Deutschen Krebsgesellschaft.